Leading diagnostic chain Dr Lal PathLabs is all set to launch its initial public offering (IPO) soon. The company has already received Securities and Exchange Board of India’s (SEBI) approval for the same.
The company had filed its Draft Red Herring Prospectus (DRHP) with SEBI in September for the IPO wherein the promoters and other existing shareholders will collectively sell 1.16 crore shares of the company. The main promoter group plans to divest five percent, while other investors such as Wagner and Westbridge Crossover Fund will divest 9.1 percent stake.
Dr Lal PathLabs is a pioneer diagnostic centre in India that provides blood test services. It is believed to be the most trusted pathology lab in the country.
Company Name | CMP |
---|---|
Aster DM Healthcare | 342.00 |
Apollo Hospital Ent. | 5833.30 |
Max Healthcare Inst | 802.70 |
Narayana Hrudayalay | 1254.85 |
Global Health | 1343.90 |
View more.. |